These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 22575047)

  • 1. Water-dispersible ferrimagnetic iron oxide nanocubes with extremely high r₂ relaxivity for highly sensitive in vivo MRI of tumors.
    Lee N; Choi Y; Lee Y; Park M; Moon WK; Choi SH; Hyeon T
    Nano Lett; 2012 Jun; 12(6):3127-31. PubMed ID: 22575047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-scale synthesis of uniform and extremely small-sized iron oxide nanoparticles for high-resolution T1 magnetic resonance imaging contrast agents.
    Kim BH; Lee N; Kim H; An K; Park YI; Choi Y; Shin K; Lee Y; Kwon SG; Na HB; Park JG; Ahn TY; Kim YW; Moon WK; Choi SH; Hyeon T
    J Am Chem Soc; 2011 Aug; 133(32):12624-31. PubMed ID: 21744804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetosome-like ferrimagnetic iron oxide nanocubes for highly sensitive MRI of single cells and transplanted pancreatic islets.
    Lee N; Kim H; Choi SH; Park M; Kim D; Kim HC; Choi Y; Lin S; Kim BH; Jung HS; Kim H; Park KS; Moon WK; Hyeon T
    Proc Natl Acad Sci U S A; 2011 Feb; 108(7):2662-7. PubMed ID: 21282616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
    Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
    Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colloidal polymer-coated Zn-doped iron oxide nanoparticles with high relaxivity and specific absorption rate for efficient magnetic resonance imaging and magnetic hyperthermia.
    Das P; Salvioni L; Malatesta M; Vurro F; Mannucci S; Gerosa M; Antonietta Rizzuto M; Tullio C; Degrassi A; Colombo M; Ferretti AM; Ponti A; Calderan L; Prosperi D
    J Colloid Interface Sci; 2020 Nov; 579():186-194. PubMed ID: 32590159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging.
    Key J; Dhawan D; Cooper CL; Knapp DW; Kim K; Kwon IC; Choi K; Park K; Decuzzi P; Leary JF
    Int J Nanomedicine; 2016; 11():4141-55. PubMed ID: 27621615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
    Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
    Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biocompatibility and proteomic profiling of DMSA-coated iron nanocubes in a human glioblastoma cell line.
    Ulanova M; Gloag L; Kim CK; Bongers A; Kim Duong HT; Gooding JJ; Tilley RD; Sachdev PS; Braidy N
    Nanomedicine (Lond); 2024 Feb; 19(4):303-323. PubMed ID: 38270934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects.
    Yang L; Zhou Z; Liu H; Wu C; Zhang H; Huang G; Ai H; Gao J
    Nanoscale; 2015 Apr; 7(15):6843-50. PubMed ID: 25806860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formation of hydrated PEG layers on magnetic iron oxide nanoflowers shows internal magnetisation dynamics and generates high in-vivo efficacy for MRI and magnetic hyperthermia.
    McKiernan EP; Moloney C; Chaudhuri TR; Clerkin S; Behan K; Straubinger RM; Crean J; Brougham DF
    Acta Biomater; 2022 Oct; 152():393-405. PubMed ID: 36007780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
    Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
    Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging.
    Wang G; Zhang X; Skallberg A; Liu Y; Hu Z; Mei X; Uvdal K
    Nanoscale; 2014 Mar; 6(5):2953-63. PubMed ID: 24480995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodistribution and Tumors MRI Contrast Enhancement of Magnetic Nanocubes, Nanoclusters, and Nanorods in Multiple Mice Models.
    Naumenko V; Garanina A; Nikitin A; Vodopyanov S; Vorobyeva N; Tsareva Y; Kunin M; Ilyasov A; Semkina A; Chekhonin V; Abakumov M; Majouga A
    Contrast Media Mol Imaging; 2018; 2018():8264208. PubMed ID: 30344459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased transverse relaxivity in ultrasmall superparamagnetic iron oxide nanoparticles used as MRI contrast agent for biomedical imaging.
    Mishra SK; Kumar BS; Khushu S; Tripathi RP; Gangenahalli G
    Contrast Media Mol Imaging; 2016 Sep; 11(5):350-361. PubMed ID: 27230705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward design of magnetic nanoparticle clusters stabilized by biocompatible diblock copolymers for T₂-weighted MRI contrast.
    Balasubramaniam S; Kayandan S; Lin YN; Kelly DF; House MJ; Woodward RC; St Pierre TG; Riffle JS; Davis RM
    Langmuir; 2014 Feb; 30(6):1580-7. PubMed ID: 24479874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictable Heating and Positive MRI Contrast from a Mesoporous Silica-Coated Iron Oxide Nanoparticle.
    Hurley KR; Ring HL; Etheridge M; Zhang J; Gao Z; Shao Q; Klein ND; Szlag VM; Chung C; Reineke TM; Garwood M; Bischof JC; Haynes CL
    Mol Pharm; 2016 Jul; 13(7):2172-83. PubMed ID: 26991550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current limitations of molecular magnetic resonance imaging for tumors as evaluated with high-relaxivity CD105-specific iron oxide nanoparticles.
    Dassler K; Roohi F; Lohrke J; Ide A; Remmele S; Hütter J; Pietsch H; Pison U; Schütz G
    Invest Radiol; 2012 Jul; 47(7):383-91. PubMed ID: 22659596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly monodisperse low-magnetization magnetite nanocubes as simultaneous T(1)-T(2) MRI contrast agents.
    Sharma VK; Alipour A; Soran-Erdem Z; Aykut ZG; Demir HV
    Nanoscale; 2015 Jun; 7(23):10519-26. PubMed ID: 26010145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast Agents Based on Iron Oxide Nanoparticles for Clinical Magnetic Resonance Imaging.
    Abakumov MA; Ternovoi SK; Mazhuga AG; Chekhonin VP; Demikhov EI; Pistrak AG; Konstantinov MV; Dmitriev DM; Myshkinis BY
    Bull Exp Biol Med; 2019 Jun; 167(2):272-274. PubMed ID: 31243671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individually Stabilized, Superparamagnetic Nanoparticles with Controlled Shell and Size Leading to Exceptional Stealth Properties and High Relaxivities.
    Lassenberger A; Scheberl A; Stadlbauer A; Stiglbauer A; Helbich T; Reimhult E
    ACS Appl Mater Interfaces; 2017 Feb; 9(4):3343-3353. PubMed ID: 28071883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.